Automating Hemostasis: The UG2510 and the Shift Toward High-Throughput Coagulation Diagnostics

UG2510 Automated Coagulation Analyzer | High-Throughput Hemostasis Testing

Hospital laboratories and diagnostic centers process hundreds of coagulation panels daily—each one critical for surgical planning, anticoagulant monitoring, and thrombosis screening. Manual or semi-automated workflows have long been a bottleneck, introducing variability and slowing turnaround times.

The UG2510 Automated Coagulation Analyzer is engineered to address exactly this. It handles routine prothrombin time, activated partial thromboplastin time, and fibrinogen assays alongside specialized hemostasis testing, all within a single, automated platform. The system is built for labs that must scale without compromising precision.

What matters operationally is its ability to reduce manual pipetting, sample handling, and human error. In a mid-to-high-volume lab, that translates directly into faster result reporting and more consistent reagent usage—both of which affect patient management and operational cost.

From a procurement standpoint, the UG2510 fits into the broader trend of Chinese diagnostic manufacturers moving beyond reagent kits to offer integrated instrument-reagent systems. This vertical integration lowers per-test costs and simplifies supply chains for hospital buyers—an increasingly important factor in price-sensitive healthcare markets.

The instrument belongs to a class of mid-range analyzers that occupy the sweet spot between compact benchtop units and high-end core-lab automation. It signals that the domestic manufacturing ecosystem can now support reliable, automated coagulation testing without reliance on imported hardware.

For a lab manager evaluating workflow upgrades, the UG2510 represents a calculation: automation at a price point that competes with refurbished imports, backed by local service support. That alone changes the procurement math.

Coagulation testing is often the last domain to automate in a hematology lab. The UG2510 suggests that gap is closing—and the cost of entry is falling.

Why it matters:
For hospital systems and independent labs in China and emerging markets, the UG2510 offers a domestically produced, high-throughput alternative to legacy foreign systems. It compresses the automation timeline for hemostasis testing and reduces per-test variability in high-volume settings.

View Product →